SCHEMBL6670285

SCHEMBL6670285

CC1(C)CCSc2ccc(C#Cc3ccc(CC(=O)O)cn3)cc21

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 5/20 0.73
CYP3A4 P08684 3/20 0.73
RARA P10276 11/20 0.67
RARB P10826 11/20 0.67
RARG P13631 11/20 0.67
KMT2A Q03164 1/20 0.67
FFAR1 O14842 2/20 0.40
FFAR4 Q5NUL3 1/20 0.40
RXRA P19793 3/20 0.39
SSTR5 P35346 1/20 0.39
CRABP2 P29373 1/20 0.38
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
ACACB O00763 1/20 0.35
CYP26B1 Q9NR63 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30374281 0.88 CYP3A4 (0.69) CYP26A1CYP3A4RARARARBRARG
SCHEMBL860637 0.88 CYP3A4 (0.69) CYP26A1CYP3A4RARARARBRARG
SCHEMBL6664613 0.86 CYP3A4 (0.67) CYP26A1CYP3A4RARARARBRARG
SCHEMBL8765953 0.86 CYP3A4 (0.67) CYP26A1CYP3A4RARARARBRARG
SCHEMBL9264079 0.85 CYP26A1 (0.54) CYP26A1CYP3A4RARARARBRARG
Tazarotenic Acid SCHEMBL29466098 0.85 CYP3A4 (1.00) CYP26A1CYP3A4RARARARBRARG
Tazarotenic Acid SCHEMBL29433140 0.85 CYP3A4 (1.00) CYP26A1CYP3A4RARARARBRARG
Tazarotenic Acid SCHEMBL678713 0.85 CYP3A4 (1.00) CYP26A1CYP3A4RARARARBRARG
SCHEMBL6667181 0.84 CYP26A1 (0.52) CYP26A1CYP3A4RARARARBRARG
SCHEMBL6669248 0.84 CYP26A1 (0.52) CYP26A1CYP3A4RARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0785782-B1 USE OF DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY ALLERGAN INC (US) 2004-09-08 EP disclosed
US-5602130-A ORNITHINE DECARBOXYLASE ENZYME INHIBITOR TREATING SKIN DISORDER, INHIBITING CELL HYPERPROLIFERATION ALLERGAN 1997-02-11 US disclosed
US-5380877-A Psoriasis treatment; retinoic acid-like activity ALLERGAN, INC. (US) 1995-01-10 US disclosed
US-5354752-A A dimethylthiochroman or dimethylchroman-6-yl-ethynyl-pyridazin- or pyrimidin- or pyrazin-for treating skin disorders psoriasis ALLERGAN, INC. (US) 1994-10-11 US disclosed
US-5348972-A In treatment of skin disorders such as acne and psoriasis ALLERGAN, INC. (US) 1994-09-20 US disclosed
US-5234926-A Skin disorders ALLERGAN, INC. (US) 1993-08-10 US disclosed
EP-0284288-B1 DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID LIKE ACTIVITY ALLERGAN, INC (US) 1992-05-27 EP disclosed
US-5089509-A Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC. (US) 1992-02-18 US disclosed
EP-0284288-A1 Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity ALLERGAN, INC (US) 1988-09-28 EP disclosed